Request Deal Involvement

General Catalyst led a $168m Series B round in Odyssey Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

SVB FINANCIAL GROUP

bidder

SVB FINANCIAL GROUP

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

COLT VENTURES

bidder

COLT VENTURES

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

ODYSSEY THERAPEUTICS

target

ODYSSEY THERAPEUTICS

GENERAL CATALYST PARTNERS

bidder

GENERAL CATALYST PARTNERS

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

GREATPOINT VENTURES

bidder

GREATPOINT VENTURES

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

WALLEYE CAPITAL

bidder

WALLEYE CAPITAL

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

SR ONE LTD

bidder

SR ONE LTD

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

LOGOS CAPITAL

bidder

LOGOS CAPITAL

WOODLINE PARTNERS

bidder

WOODLINE PARTNERS

HBM HEALTHCARE INVESTMENTS

bidder

HBM HEALTHCARE INVESTMENTS

CREACION VENTURES

bidder

CREACION VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - General Catalyst led a $168m Series B round in Odyssey Therapeutics.